$40M backs portable MRI system for ICU, ER and office brain scans Initial funding totals $15M, with up to $25M more available as Hyperfine expands its portable brain imaging system across hospitals and clinics.

#HRZN #HYPR Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

www.stocktitan.net/news/HRZN/horizon-techno...

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results Hyperfine (Nasdaq: HYPR) reported Q4 and full-year 2025 results and a business update on March 18, 2026. Q4 revenue was $5.29M (+128% YoY) and full-year revenue was $13.56M. Q4 gross margin improved to 51%. Cash was $35.09M as of Dec 31, 2025.Company secured equity and debt financing, obtained regulatory clearance in India, received a $3.7M Gates Foundation grant, and provided 2026 guidance of $20–22M revenue with reduced cash burn.

#HYPR Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

www.stocktitan.net/news/HYPR/hyperfine-inc-...

AI-powered portable MRI maker Hyperfine sets March 18 earnings call Investors can hear Hyperfine management review Q4 and full-year 2025 financial results on March 18 via a webcast and replay on its investor website.

#HYPR Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

www.stocktitan.net/news/HYPR/hyperfine-inc-...

Yo I am back on #hyprland and I have a Brand New linux rice made. I would say I'm pretty good at arch linuxing at this point. Not at all an expert or anything. But I'm confident!

#arch #archlinux #computers #hypr #errorfix #dotfiles #shortrecap #horriblecomputer

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities Hyperfine (Nasdaq: HYPR) published the largest dataset to date on stroke detection with the Swoop® portable MRI, a prospective multi-center observational study of 95 patients published in Stroke: Vascular and Interventional Neurology. The next-generation Swoop with an advanced multi-directional DWI sequence detected lesions as small as 2.8 mm (0.15 mL), achieved 100% sensitivity and 100% specificity for lesions >1.0 mL, and reduced scan time by approximately 30%. The advanced DWI sequence was recently cleared by the FDA. Systems were provided under sponsored research agreements; the company was not involved in study design, analysis, or publication decisions.

#HYPR Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain— the Swoop ® system— today announced results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico on...

#HYPR Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents Hyperfine (Nasdaq: HYPR) announced enrollment of the first patient in the Contrast PMR study, a prospective, multi-center trial to test contrast-enhanced ultra-low-field portable MRI using the Swoop system. The study will enroll approximately 70 patients across U.S. sites and will evaluate three endpoints related to visualization of brain lesions, including those tied to blood-brain barrier disruption. The trial is intended to support a future FDA 510(k) submission to expand the Swoop system's intended use to include gadolinium-based contrast agents, with a potential submission anticipated toward the end of 2026.ClinicalTrials.gov identifier: NCT07296263. More information at HyperfineMRI.com.

#HYPR Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results Hyperfine (Nasdaq: HYPR) reported preliminary, unaudited Q4 2025 revenue of approximately $5.3M, +127% year-over-year and +54% sequentially, and preliminary full-year 2025 revenue of approximately $13.5M, +5% year-over-year. Preliminary Q4 2025 net cash burn excluding financings was ~$5.7M and preliminary full-year 2025 net cash burn was ~$29.9M, down 30% and 22% versus prior periods, respectively. Preliminary cash and cash equivalents were approximately $35.1M as of December 31, 2025. The company cited record Q4 placements, product launches, and expansion into neurology offices and international markets, and will release audited results and 2026 outlook on its March 2026 earnings call.

#HYPR Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

www.stocktitan.net/news/HYPR/hyperfine-repo...

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care Hyperfine (Nasdaq: HYPR) announced a peer‑reviewed Clinical Neuroimaging publication showing economic benefits of the Swoop® AI‑powered portable MRI in acute hospital care.A 12‑month retrospective analysis of 143 patients at Jefferson Abington Hospital found the Swoop system eliminated MR‑compatible equipment costs (averaging $590 per patient) and reduced MRI wait times by an average of 18 hours for ICU and ED patients, driving measurable cost avoidance and throughput improvements that could translate to tens to hundreds of thousands of dollars in annual savings depending on utilization.

#HYPR Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Announces Regulatory Approval of the Swoop® System in India Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain— the Swoop ® system— today announced the Swoop ® system has received regulatory approval in India from the Central Drugs Standard Control Organization, opening access to advanced brain...

#HYPR Hyperfine Announces Regulatory Approval of the Swoop® System in India

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health Hyperfine (Nasdaq: HYPR) received a $3.7 million Gates Foundation grant to expand AI-powered portable neonatal MRI work through 2028. Funding will accelerate AI pipelines and technical innovation for the Swoop® portable MRI to evaluate infant neurodevelopment in resource-constrained settings as part of the UNITY project led by King’s College London.The UNITY consortium spans >40 centers across low-, middle-, and high-income countries and has performed >10,000 examinations, including scans of >6,000 babies across five continents; the grant targets improved image clarity and diagnostic reliability for neonatal scans.

#HYPR Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

www.stocktitan.net/news/HYPR/hyperfine-awar...

#HYPR Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/HYPR/hyperfine-inc-...

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting Hyperfine (Nasdaq: HYPR) announced that the PRISM PMR study has enrolled its first patients to evaluate the Swoop® portable MRI system in the neurosurgical operating room.PRISM PMR (PRe- and post-operatIve Study of iMaging with Portable MR) will collect real-world data over three months at Atlas Surgery Center in Buffalo, NY, led by principal investigator Dr. Elad Levy. The study will assess pre- and post-procedure imaging across diverse neurosurgical procedures, detection of post-operative complications (stroke, bleeding), and workflow integration to support faster discharge and recovery.

#HYPR Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

www.stocktitan.net/news/HYPR/hyperfine-anno...

Trade Alerts, Thursday October 16, 2025 – Crystal Equity Research

Small-cap stocks with strong volume declines, Thu Oct 16th - #WBUY #TOYO #YDKG #UROY #SATL #OCCI #LOOP #KZR #HYPR #GBIO #FOSL #CCII #ARTV #IIIN - More: crystalequityresearch.com/trade-alerts... - #smallcap

Hyperfine Announces Pricing of $17.5 Million Public Offering Hyperfine (Nasdaq: HYPR) priced a registered underwritten public offering of 14,000,000 Class A shares at $1.25 per share, with gross proceeds to the company of approximately $17.5 million before fees. The underwriter has a 30-day option to purchase up to 2,100,000 additional shares (15% of the offering) at the same public price less underwriting discounts.The offering is expected to close on or about October 17, 2025, subject to customary closing conditions. Lake Street Capital Markets is sole book-runner. Proceeds are intended for working capital and general corporate purposes, including commercial, manufacturing, and R&D. The securities are offered under an effective Form S-3 shelf registration.

#HYPR Hyperfine Announces Pricing of $17.5 Million Public Offering

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Announces Proposed Public Offering Hyperfine (Nasdaq: HYPR) announced on October 15, 2025 that it has commenced an underwritten public offering of its Class A common stock or, for certain investors, pre-funded warrants to purchase Class A common stock. The company said all securities will be sold by Hyperfine and that underwriters will have a 30-day option to buy up to 15% of the total securities on the same terms. The offering is subject to market and other conditions and may not be completed.Lake Street Capital Markets is sole book-runner. The securities are offered from an effective Form S-3 shelf registration (filed Nov 9, 2023; declared effective Nov 22, 2023). Final terms will be disclosed in a prospectus supplement filed with the SEC.

#HYPR Hyperfine Announces Proposed Public Offering

www.stocktitan.net/news/HYPR/hyperfine-anno...

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain— the Swoop ® system— today announced the launch of the Portable Ultra-Low-Field Scientific Exchange, a subscription-based platform designed to empower a global community of clinical...

#HYPR Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

www.stocktitan.net/news/HYPR/hyperfine-laun...

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software Hyperfine (NASDAQ: HYPR) has secured CE Mark and UKCA approval for its Optive AI™ software, expanding the global reach of its AI-powered imaging technology. The software enhances the Swoop® portable MRI system's image quality through advanced AI processing at multiple stages, from noise cancellation to post-processing.The approval follows recent FDA clearance and enables deployment in European and UK markets starting Q4 2025. The software upgrade is compatible with first-generation Swoop® systems without hardware modifications, offering enhanced brain imaging capabilities for various clinical applications including stroke, pediatric care, and neurodegenerative conditions.

#HYPR Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

www.stocktitan.net/news/HYPR/hyperfine-rece...

Hyperfine's AI-powered portable MRI system gets FDA clearance as revenue jumps 26% Hyperfine secured FDA approval for Optive AI software and next-gen Swoop portable MRI system. Q2 revenues hit $2.7M with improved margins. See full results.

#HYPR Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/HYPR/hyperfine-inc-...

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System Hyperfine (Nasdaq: HYPR) has reached a significant milestone in its NEURO PMR study, enrolling 100 patients within just 16 weeks, ahead of the planned schedule. The study, conducted at DENT Neurologic Institute and Texas Neurology, evaluates the company's next-generation Swoop® system, an FDA-cleared AI-powered portable MRI system for brain imaging in outpatient settings.The multi-center study compares portable ultra-low-field MRI with conventional high-field MRI in neurology offices, with results expected in early 2026. The company has strategically partnered with NeuroNet Pro, the largest U.S. association of independent neurology practices, to expand commercial adoption. The milestone follows Hyperfine's successful office pilot program, where early adopters implemented Swoop® systems and obtained reimbursement from CMS and private insurers.

#HYPR Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

www.stocktitan.net/news/HYPR/hyperfine-achi...

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments Hyperfine (Nasdaq: HYPR) has announced the initiation of the PRIME (Portable Rapid Imaging for Medical Emergencies) study, enrolling its first patients at Yale School of Medicine. The study will evaluate the company's AI-powered Swoop® portable MRI system in emergency department settings.The PRIME study expands upon the previous ACTION PMR study and will utilize the next-generation Swoop® system with Optive AI™ software, featuring enhanced image quality and sharper anatomical detail. The research aims to assess the technology's effectiveness as a triage tool for various brain-related emergency conditions in a Level 1 emergency department.Led by Dr. Kevin Sheth and Dr. Adam De Havenon, the study focuses on addressing critical challenges in emergency departments, including patient boarding and limited MRI access. The initiative aligns with Hyperfine's strategy to drive commercial growth by demonstrating how portable MRI can improve clinical workflows and diagnostic access at the point of care.

#HYPR Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

www.stocktitan.net/news/HYPR/hyperfine-anno...

AI Medical Tech Leader Hyperfine Sets Q2 Earnings Date: Latest Financial Results from Portable MRI Innovator Leading AI-powered portable MRI maker announces Q2 2025 results webcast. Join management discussion on Aug 13 to learn latest growth metrics. Get insights.

#HYPR Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

www.stocktitan.net/news/HYPR/hyperfine-inc-...

Revolutionary Portable MRI Could Help 57M Dementia Patients Access Better Care, New Studies Show Hyperfine's AI-powered Swoop MRI system enables single-visit dementia screening in outpatient settings. New clinical trials reveal breakthrough results. Learn more.

#HYPR Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

www.stocktitan.net/news/HYPR/hyperfine-swoo...

Revolutionary AI Software Transforms Portable MRI Quality: Hyperfine's New Optive AI Cuts Scan Time by 40% New Optive AI software enhances Swoop portable MRI systems with superior image clarity and 40% faster FLAIR scans. See how this breakthrough transforms brain imaging.

#HYPR Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

www.stocktitan.net/news/HYPR/hyperfine-begi...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume gains, Thu Jul 17th - #VVPR #PDYN #NNDM #MCRI #ADV #BZAI #CGEN #DPRO #EPIX #HYPR #XXII #SAIH #OPEN #LAZR #IRIX #WDH #SPCE #NMG #LAC #IH #BRCC #WINT - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software Hyperfine (Nasdaq: HYPR) has announced its first commercial sales of the next-generation Swoop® Portable MR Imaging system, powered by Optive AI™ software. Two leading hospitals in the northeastern United States have purchased the units following recent FDA clearance, planning to deploy them in intensive care units and emergency departments.The new Swoop® system features enhanced signal-to-noise ratio and, combined with Optive AI™ software, delivers improved image resolution, uniformity, and faster acquisition times. The system's patient-centric design makes it particularly suitable for pediatric, elderly, and anxious patients, advancing Hyperfine's mission to transform MRI accessibility.

#HYPR Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

www.stocktitan.net/news/HYPR/hyperfine-anno...

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! Weekly Top Unu

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

Weekly Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #HYPR 183% OTM
2. #MSTR 68% OTM
3. #WOLF 55% OTM
4. #PONY 46% OTM
5. #ZENA 44% OTM

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#HYPR, #WOLF, #PONY, #IOT, #RIVN

#OptionFlow #OptionsTrading #Trading

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #HYPR 183% OTM
2. #WOLF 60% OTM
3. #PONY 46% OTM
4. #PLTR 34% OTM
5. #MRVL 33% OTM

#OptionFlow #OptionsTrading #Trading